Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA – January 2016
This report describes the geographical and temporal distribution of multidrug-resistant tuberculosis based on molecular typing data (24-locus MIRU–VNTR genotyping) as reported by EU/EEA countries.
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis (TB) using molecular typing data reported by European Union (EU)/European Economic Area (EEA) Member States for 2015 and the preceding years.
ERLN-TB expert opinion on the use of the rapid molecular assays for the diagnosis of tuberculosis and detection of drug resistance
According to this report, the use of rapid molecular assays has diagnostic value in tuberculosis (TB) identification and detection of drug resistance, although there is not enough evidence to recommend these tools in all populations and situations and they should not replace standard diagnostic methods.
Tuberculosis surveillance and monitoring in Europe 2015
The seventh report launched jointly by ECDC and the WHO Regional Office for Europe indicates that, despite notable progress in the past decade, tuberculosis (TB) is still a public health concern in many countries across Europe.
Rapid risk assessment: multidrug-resistant tuberculosis in migrants, multi-country cluster - 2nd update, 27 March 2017
This second update provides information regarding the risk of EU transmission of an MDR TB clone initially detected in seven asylum seekers from the Horn of Africa who currently reside in Switzerland.
Multidrug-resistant tuberculosis in migrants, multi-country cluster - 3rd update, 13 April 2017
A multi-country cluster of multidrug-resistant tuberculosis (MDR TB) involving 28 migrants has been delineated by whole genome sequencing (WGS) in migrants recently having arrived from countries in the Horn of Africa.
Molecular surveillance of multi- and extensively drug-resistant tuberculosis transmission in the European Union from 2003 to 2011
De Beer, J.L., Ködmön, C., van der Werf, MJ., van Ingen, J., van Soolingen, D., the ECDC MDR-TB molecular surveillance project participants
First Evaluation after Implementation of a Quality Control System for the Second Line Drug Susceptibility Testing of Mycobacterium tuberculosis Joint Efforts in Low and High Incidence Countries
Hillemann, D., Hoffner, S., Cirillo, D., Drobniewski, F., Richter, E., Rusch-Gerdes, S.